The IT consulting firm Saviance Technologies has grown to more than 200 people across the U.S. and about $15 million in revenue since it was founded 13 years ago.
Now the Metuchen-based company, which sends IT professionals to work at client locations nationwide, hopes to achieve a big growth spurt with its own suite of proprietary solutions targeted to the pharmaceuticals, life sciences and health care industries.
It is those three sectors that Chief Executive Gurudas Sarkar sees offering the most growth opportunity for the products and services he believes will put the company on the cutting edge of mobile device innovation and big data analytics.
His goal: “To become a global service provider of next generation” IT solutions to the health and pharma sectors.
Saviance is offering big pharmaceutical companies a platform to handle the huge amounts of data in new-drug development.
“Let's say you're developing a breast cancer drug,” he said. “We can give you some dynamic analytics in terms of the demographic profile of the potential patients. What kind of patients have breast cancer? What is their age, socio- economic condition, nutrition habits, family background, the environment where they grew up?”
Sarkar said for the past year and a half, Saviance has been working with a major U.S. cancer research center that needs this kind of big data analytics for its clinical trials.
Besides big data, another key area for Saviance is mobility.
“We are introducing an approach that we call 'multi-channel mobile development,'” Sarkar said.
For example, a big drug company wants to communicate with employees and customers via their mobile devices — but these devices come in nearly 50 different flavors, from Blackberry to iPhone 5.
Sarkar said the Saviance multi-channel approach is designed “to produce one application that will operate on every device and give the same user experience — and obviously the cost of development will come down.”
Sarkar said the health care IT market is poised for big growth, driven by the need for technology to support new drug development and to monitor and improve the delivery of health care.
“Our solutions will be required in every place — at the doctor's office, at the hospitals, at the pharma company — everyone needs our services,” he said.
E-mail to: email@example.com
On Twitter: @bethfitzgerald8